Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study. [PDF]
Hansen DK +29 more
europepmc +1 more source
ABSTRACT Permafrost is rapidly degrading in the sporadic zone, including palsa mires in Scandinavia. Peatlands in the area have likely accumulated heavy metals from atmospheric deposition of industrial contaminants in the wider region. As the palsa mire chemical composition is not well known, and in other permafrost regions the permafrost thaw may ...
Joanna Katarzyna Jóźwik +7 more
wiley +1 more source
Youth partner engagement in the development of an integrated care pathway for the treatment of adolescents with depression. [PDF]
Prebeg M +7 more
europepmc +1 more source
Author Correction: Quantifying forest disturbance regimes within caribou (Rangifer tarandus) range in British Columbia. [PDF]
Maltman JC +4 more
europepmc +1 more source
Efficacy and safety of talquetamab in relapsed/refractory multiple myeloma and renal impairment: a quaternary cancer center cohort. [PDF]
Ali HM +21 more
europepmc +1 more source
CRS or ICANS Are Rare Beyond 2 Weeks After Lisocabtagene Maraleucel Infusion: Data From Clinical Trials and the Real-World Setting. [PDF]
Hunter BD +18 more
europepmc +1 more source
Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma. [PDF]
Jagannath S +32 more
europepmc +1 more source
The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy Consortium real-world experience. [PDF]
Afrough A +45 more
europepmc +1 more source
Five-Year Follow-Up Analysis of ZUMA-5: Axicabtagene Ciloleucel in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma. [PDF]
Neelapu SS +22 more
europepmc +1 more source
Caribou and Reindeer Population Cycles Are Driven by Top-Down and Bottom-Up Mechanisms Across Space and Time. [PDF]
Clark-Wolf TJ +3 more
europepmc +1 more source

